Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ICCCICCC
Showing 8 of 13 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in IMMUCELL CORP

CITADEL ADVISORS LLC holds 40,503 shares of ICCC (IMMUCELL CORP), worth $407,055 as of 2026-Q2. The position was increased (+13.5% shares).

Current Value

$407,055

Current Shares

40,503

Total Value Change

+$407,055

Total Shares Change

+40,503

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
40,503
+13.5%
$407,0550.0%$10.05
18
2026-Q1
Decreased
35,696
-9.4%
$225,9560.0%$6.40
0
2025-Q4
Increased
39,393
+83.5%
$242,2670.0%$6.11
24
2025-Q3
Decreased
21,469
-47.6%
$138,9040.0%$6.18
0
2025-Q2
Increased
40,951
+71.0%
$285,0190.0%$6.75
24
2025-Q1
Decreased
23,945
-17.5%
$114,6970.0%$5.01
0
2024-Q4
New
29,021
-
$149,4580.0%$4.82
34
2024-Q3
Exited
0
-100.0%
$00.0%$3.55
0

Other major holders of ICCC: VANGUARD CAPITAL MANAGEMENT LLC, MORGAN STANLEY, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used